跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AP-40
首页
药物
AP-40
AP-40
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US 8101209 B2
申请人: LEGRAND VALERIE
优先权: 2004
CN
US
3 件公开
Single chain antibodies against -amyloid peptide
US 8124076 B2
申请人: SOLOMON BEKA
优先权: 2006
US
3 件公开
Aqueous composition comprising a cationic cellulosic polymer, an anionic surfactant comprising at least one cationic counterion, a fatty phase and a pigment
US 11771639 B2
申请人: OREAL
优先权: 2019
CN
US
2 件公开
Compressed tablets comprising microcapsules with modified release
US 2005266078 A1
申请人: JORDA RAFAEL
优先权: 2002
US
2 件公开
Oligonucleotide decoys and methods of use
US 8372966 B2
申请人: UNIV CINCINNATI
优先权: 2004
US
2 件公开
Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles
US 2005037077 A1
申请人: LEGRAND VALERIE
优先权: 2001
US
Antitumor genetic transcription regulating medicine
CN 1506117 A
申请人: NANJING KAIJI BIOLOG SCI TECH
优先权: 2002
CN
Charging cosmetic makeup composition for keratin fibers
US 2005229332 A1
申请人: OREAL
优先权: 2004
US
COMPOSITIONS AND USES
US 2012321694 A1
申请人: LAROCQUE DANIEL
优先权: 2012
US
Red complex probiotics composition for heart and cerebral vessels
CN 106389763 A
申请人: CHENGDU LIURAN MEDICAL TECH CO LTD
优先权: 2016
CN
第 1 / 2 页
上一页
下一页
药物
反馈